Vroom, Inc. (NasdaqGM: VRM) has been removed from the Russell 3000 Value Benchmark. This news follows a series of recent announcements, including the company being dropped from other Russell indices and reporting its first-quarter earnings for 2026. Vroom operates United Auto Credit Corporation (UACC) and CarStory, LLC, offering vehicle financing and AI-powered analytics for automotive retail.

American Electric Power's "Neighbor to Neighbor Program" provides bill-payment assistance to low-income households in its service territories. Funded by customer and company donations, the program offers one-time grants to prevent service disconnections, working through local social-service agencies. This initiative helps balance shareholder returns with community engagement and reduces bad debt for AEP.

Two Harbors Investment Corp. (NYSE: TWO) has been removed from the Russell 3000E Growth Benchmark. This news comes amidst recent updates regarding the company's dividend declarations and ongoing discussions related to a proposed takeover by UWM Holdings Corporation, with the board unanimously recommending a transaction with CrossCountry Mortgage.

Zacks Research has slightly lowered its Q2 2026 EPS estimate for Terex to $1.24, maintaining a Hold rating, while the consensus full-year estimate is $4.84. Other analysts generally hold a positive outlook, with several "Buy" ratings and an average price target of $75.82, resulting in an overall "Moderate Buy" consensus. Terex recently surpassed its quarterly earnings and revenue expectations ($0.98 EPS on $1.73 billion revenue) and reaffirmed its FY 2026 guidance of $4.50 to $5.00 EPS.

Toyota Motor (TM) reported its fourth consecutive monthly drop in global vehicle sales for May, primarily due to significant slumps in sales in China and the Middle East. Overall, global sales decreased by 7.2% year-on-year to 834,279 vehicles.

Pfizer's ecnoglutide and Innovent Biologics' mazdutide have passed a preliminary review for inclusion in China's basic medical insurance drug catalogue. Both GLP-1 receptor agonist drugs are approved in China for weight management and type II diabetes. Innovent clarified that only diabetes treatment could be considered for medical insurance coverage in China.

The U.S. Justice Department has concluded its criminal investigation into Abbott Laboratories regarding its baby formula plant, opting for civil penalties instead of criminal charges. This decision follows a 2022 recall and plant closure due to bacterial contamination, which worsened a national baby formula shortage. The DOJ emphasized food safety as a priority, indicating that this outcome reflects a focus on regulatory oversight without pursuing criminal action against the company.

Apple's reported interest in buying memory chips from Chinese manufacturer ChangXin Memory Technologies (CXMT) is driven by concerns over a widening supply-demand gap in the memory market, particularly due to the growing demands of AI data centers, rather than a desire for lower prices. Analyst Ming-Chi Kuo suggests that Apple is seeking supply security as the global memory imbalance is expected to worsen through 2027. This push for CXMT is aimed at mitigating DRAM supply risk, contrasting with previous efforts to reduce NAND costs.

Lockheed Martin successfully intercepted a Group 3 drone using its JAGM missile fired from a GRIZZLY containerized launcher, demonstrating a rapid deployment capability against drone threats. The entire system integration and testing were completed in under 45 days, showcasing its agility and affordability for both land and maritime platforms. This achievement highlights Lockheed Martin's focus on delivering cost-effective, scalable layered defense solutions.

Market commentator Bull Theory, citing Morgan Stanley's latest housing outlook, suggests that housing affordability in the U.S. is unlikely to return to pre-2022 levels, even with lower mortgage rates. Morgan Stanley's models show mortgage payments remaining high relative to household income across various interest rate scenarios. This persistent unaffordability is attributed to factors like existing homeowners' low mortgage rates, limited housing supply, restrictive policies, and rising insurance costs, leading to a slow housing market and a shift towards more renters.